Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, Sawyer J (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988–994, 10496257, 10.1212/WNL.53.5.988, 1:STN:280:DyaK1MvisVGktA%3D%3D
World Health Organization (2004) Headache disorders. http://www.who.int/mediacentre/factsheets/fs277/en/ . Accessed July 2010
Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11(4):289–299, 20473702, 10.1007/s10194-010-0217-0
Stovner LJ, Andree C, Eurolight Steering Committee (2008) Impact of headache in Europe: a review for the Eurolight project. J Headache Pain 9(3):139–146, 18418547, 10.1007/s10194-008-0038-6
Mennini FS, Gitto L, Martelletti P (2008) Improving care through health economics analyses: cost of illness and headache. J Headache Pain 9(4):199–206, 18604472, 10.1007/s10194-008-0051-9
Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby P, Gobel H, Lainez M, Lance J, Lipton R, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746, 16686915, 10.1111/j.1468-2982.2006.01172.x, 1:STN:280:DC%2BD283mt1Gruw%3D%3D
Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: a field study of revised IHS criteria. Neurology 47:871–875, 8857711, 10.1212/WNL.47.4.871, 1:STN:280:DyaK2s%2FhtVKkug%3D%3D
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache 48:1157–1168, 18808500, 10.1111/j.1526-4610.2008.01217.x
Reed ML, Buse DC, Manack AN, Fanning KM, Serrano D, Turkel CC, Lipton RB (2011) Prevalence of chronic migraine (CM), headache-related disability and sociodemographic factors in the US population. Headache 51(S1):28
Natoli J, Manack A, Dean B, Butler Q, Turkel C, Stovner L, Lipton R (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia 30:599–609, 19614702, 1:STN:280:DC%2BC3cfntVSqsQ%3D%3D
Kavuk I, Cetindere U, Agelink MW, Diener HC (2003) Epidemiology of chronic daily headache. Eur J Med Res 8(6):236–240, 12911872, 1:STN:280:DC%2BD3sznslensA%3D%3D
Bigal ME, Rapoport AM, Lipton RB et al (2003) Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) questionnaire. A comparison of chronic migraine with episodic migraine. Headache 3:336–342, 10.1046/j.1526-4610.2003.03068.x
Bigal ME, Serrano D, Reed M, Lipton RB (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71(8):559–566, 18711108, 10.1212/01.wnl.0000323925.29520.e7
Buse DC, Manack AN, Serrano D, Varon SF, Turkel CC, Lipton RB (2012) Headache-impact of chronic and episodic migraine: results from the AMPP study. Headache 52(1):3–17, 22106869, 10.1111/j.1526-4610.2011.02046.x
Buse DC, Manack A, Serrano D, Turkel C, Lipton RB (2010) Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 81(4):428–432, 20164501, 10.1136/jnnp.2009.192492, 1:STN:280:DC%2BC3c3ivFGisA%3D%3D
Meletiche DM, Lofland JH, Young WB (2001) Quality of life differences between patients with episodic and transformed migraine. Headache 41:573–578, 11437893, 10.1046/j.1526-4610.2001.041006573.x, 1:STN:280:DC%2BD38%2FhvFKntw%3D%3D
Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB (2010) Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med 52(1):8–14, 20042889, 10.1097/JOM.0b013e3181c1dc56
Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, Manack A, Proskorovsky I, Gladstone J, Buse DC, Varon SF, Goadsby PJ, Blumenfeld AM (2011) Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache 51(7):1058–1077, 21762134, 10.1111/j.1526-4610.2011.01945.x
Guitera V, Muñoz P, Castillo J, Pascual J (2002) Quality of life in chronic daily headache: a study in a general population. Neurology 58(7):1062–1065, 11940693, 10.1212/WNL.58.7.1062
Colás R, Muñoz P, Temprano R, Gómez C, Pascual J (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62(8):1338–1342, 15111671, 10.1212/01.WNL.0000120545.45443.93
Antonaci F, Dumitrache C, De Cillis I, Allena M (2010) A review of current European treatment guidelines for migraine. J Headache Pain 11:13–19, 20020170, 10.1007/s10194-009-0179-2
Michel P, Auray J, Chicoye A, Dartigues J, Lamure M, Duru G, Henry P, Salamon R (1993) Prise en charge des migraineux en France: coût et recours aux soins. J d’Econ Méd 11:71–80
Neubauer G, Ujlaky R (2002) Migraine-a disease and its costs. Pharm Unserer Zeit 31:494–497, 12369168, 10.1002/1615-1003(200209)31:5<494::AID-PAUZ494>3.0.CO;2-G
van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FF (1995) Societal perspective on the burden of migraine in The Netherlands. Pharmacoeconomics 7:170–179, 10155303, 10.2165/00019053-199507020-00008
Berg J, Stovner LJ (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12(Suppl. 1):59–62, 15877781, 10.1111/j.1468-1331.2005.01192.x
Payne KA, Varon SF, Kawata AK, Yeomans K, Wilcox TK, Manack A, Buse DC, Goadsby PJ, Lipton RB, Blumenfeld AM (2011) The International Burden of Migraine Study (IBMS): study design, methodology and baseline cohort characteristics. Cephalalgia 31:1116–1130, 21690175, 10.1177/0333102411410610
Stewart WF, Lipton RB, Dowson AJ, Sawyer J (2001) Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 56(6 Suppl 1):S20–S28, 11294956, 10.1212/WNL.56.suppl_1.S20, 1:STN:280:DC%2BD3M3ivVGntA%3D%3D
Stewart WF, Lipton RB, Kolodner K (2003) Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms. Headache 43(3):258–265, 12603645, 10.1046/j.1526-4610.2003.03050.x
Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J (1999) Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 19:107–114, 10214536, 10.1046/j.1468-2982.1999.019002107.x, 1:STN:280:DyaK1M3jtFWmsw%3D%3D
Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, Goadsby PJ, Lipton RB (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 31(3):301–315, 20813784, 10.1177/0333102410381145, 1:STN:280:DC%2BC3M7lsFKkuw%3D%3D
AMELI (2010) L’Assurance maladie en ligne. http://www.ameli.fr . Accessed May 2010
Kassenarztliche Bundesvereinigung (2010) Einheitlicher Bewertungsmassstab (EBM). http://www.kbv.de/8144.html . Accessed March 2010
Department of Health (2010) Publications and Statistics NHS Reference Costs 2007–2008. http://www.dh.gov.uk/en/Publicationsandstatistics/index.htm . Accessed May 2010
PSSRU (2011) Unit Costs of Health and Social Care 2007 http://www.pssru.ac.uk/uc/uc2007contents.htm#contents . Accessed May 2011
Ministero della Salute (2008) Tariffa euro in vigore da prenotazioni, Lombardia (unpublished)
Diario Oficial de Galicia, núm 199 del 9 de octubre 2009, pg 15997
Boletín Oficial del País Vasco, núm. 69 del 14 de abril del 2009
Boletín Oficial de la Junta de Andalucía, núm. 210 del 27 de octubre de 2005, pg 46
Diari Oficial de la Comunitat Valenciana, núm 5922 de 29 de diciembre del 2008, pg 93310
Curepoint (2010) Acupuncture in Bristol. http://www.curepoint.co.uk/acupuncture-fees.shtml . Accessed May 2010
Energetique Traditionnelle Chinoise (2010) http://www.energetiquechinoise.com/index.php?id=1#acupuncture . Accessed May 2010
Consumer Eroski (2010) La acupunctura. http://www.consumer.es/web/es/salud/investigacion_medica/2004/06/14/104193.php . Accessed May 2010
EUMed.it (2010) Tariffa Unica Convenzionale per le Prestazioni di Assistenza Ospedaliera per Acuti 2006. http://www.eumed.it/drg/TUC_2006.pdf . Accessed May 2010
InEK—Institut für das Entgeltsystem im Krankenhaus (2010) G-DRG—System 2010. http://www.g-drg.de/cms/index.php/inek_site_de/G-DRG-System_2010 . Accessed March 2010
Registro de Altas de los Hospitales Generales del Sistema Nacional de Salud. CMBD (2010) Norma Estatal 2007 Ministerio de Sanidad y Politica Social. http://www.msc.es/estadEstudios/estadisticas/cmbd.htm . Accessed April 2010
Williams AE, Lloyd AC, Watson L, Rabe KF (2006) Cost of scheduled and unscheduled asthma management in seven European Union countries. Eur Respir Rev 15:1–9, 10.1183/09059180.06.00009801
British National Formulary v58 (2010) http://bnf.org/bnf . Accessed May 2010
Nomenclátor de Facturación (2010) Ministerio de Sanidad y Politica Social de España. http://www.msps.es/profesionales/farmacia/frmNomenclator.jsp . Accessed April 2010
Rote list (2010) http://www.rote-liste.de . Accessed March 2010
Pneumonet (2010) Area Scientifica. Prontuario. http://www.pneumonet.it/scientifico/prontuario/ . Accessed May 2010
Consulting Room (2010) Vistabel information and background. http://www.consultingroom.com/Treatment_FAQs/Product_Display.asp?Product_ID=98&Vistabel-® . Accessed May 2010
Ophthalmologic Centre for Diagnosis and Treatment (2010) http://www.ophtalmo-centre.fr/eng/techniques/esthetics.htm . Accessed May 2010
Nagy AJ, Gandhi S, Bhola R, Goadsby PJ (2011) Intravenous dihydroergotamine (DHE) for inpatient management of refractory primary headaches. Neurology 77:1827–1832, 22049203, 10.1212/WNL.0b013e3182377dbb, 1:CAS:528:DC%2BC3MXhsVKgtrrO
Afridi SK, Shields KG, Bhola R, Goadsby PJ (2006) Greater occipital nerve injection in primary headache syndromes—prolonged effects from a single injection. Pain 122:126–129, 16527404, 10.1016/j.pain.2006.01.016, 1:STN:280:DC%2BD283jsFKktw%3D%3D
Berg J (2004) Economic evidence in migraine and other headaches: a review. Eur J Health Econ 5(Suppl 1):S43–S54, 15754073, 10.1007/s10198-005-0288-z
Pradalier A, Auray JP, El Hasnaoui A, Alzahouri K, Dartigues JF, Duru G, Henry P, Lantéri-Minet M, Lucas C, Chazot G, Gaudin AF (2004) Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study. Pharmacoeconomics 22(15):985–999, 15449963, 10.2165/00019053-200422150-00003
Badia X, Magaz S, Gutiérrez L, Galván J (2004) The burden of migraine in Spain: beyond direct costs. Pharmacoeconomics 22(9):591–603, 15209528, 10.2165/00019053-200422090-00004
Linde M, Gustavsson A, Stovner LJ et al (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19(5):703–711, 22136117, 10.1111/j.1468-1331.2011.03612.x, 1:STN:280:DC%2BC38zot1yrsA%3D%3D